Key Statistics
- First-line treatment for ADHD
- ~70% respond to initial stimulant
- ~90% respond when trying both classes
- 40% respond equally to both classes
- 20% respond to only one class
Key Medication Classes
Methylphenidate
- Blocks dopamine/norepinephrine reuptake
- Often safer starting option
- Better for patients with anxiety/mood disorders
- Examples: Concerta, Ritalin, Focalin
Amphetamines
- Blocks reuptake AND increases neurotransmitter release
- More potent but higher side effect risk
- Higher potential for misuse
- Examples: Adderall, Vyvanse, Dexedrine
Choosing Between Classes
Start with Methylphenidate if:
- History of substance use
- Concerns about side effects
- Comorbid mood disorders
- Need smoother effect
Start with Amphetamines if:
- Previous good response
- Need stronger symptom control
- Methylphenidate insufficient
- Severe ADHD symptoms
Key Formulation Factors
-
Enantiomer Composition
- Amphetamines: D-amphetamine vs L-amphetamine
- Methylphenidate: Dexmethylphenidate vs Levomethylphenidate
- Different ratios affect potency and side effects
-
Route of Administration
- Primarily pills for adults
- Alternatives: ODT, chewables, liquids, patches
-
Release Mechanism
- Immediate Release (IR): 3–6 hours
- Extended Release (ER): 8–12 hours
- Most adults benefit from ER formulations
Prodrugs
Lisdexamphetamine (Vyvanse):
- Inactive until metabolized
- Lower abuse potential
- Smoother action
- Once-daily dosing
Serdexmethylphenidate (Azstarys):
- Combines immediate and extended control
- Gradual metabolism
Practical Guidelines
-
Starting Treatment
- Begin with long-acting formulation
- Use symptom rating scales (ASRS)
- 1–2 month initial trial
- Aim for 50% symptom improvement
-
Dosing
- Start low, titrate slowly
- Amphetamine: 5–10 mg daily
- Methylphenidate: 10–20 mg daily
- Adjust based on response
-
When to Switch
- Insufficient response
- Significant side effects
- ~30% who don't respond to one class will respond to the other
IR Stimulant Uses
- Targeted symptom needs
- Variable schedules
- Side effect management
- Reduced long-term exposure
- Individual metabolism considerations


_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747)



